{
    "2019-10-24": [
        [
            {
                "time": "2019-10-24",
                "original_text": "美盈森人造肉产品实现阶段性成果、太极股份与华为成立联合创新实验室.",
                "features": {
                    "keywords": [
                        "美盈森",
                        "人造肉",
                        "太极股份",
                        "华为",
                        "联合创新实验室"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "食品科技",
                        "信息技术"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-24",
                "original_text": "云南白药：上榜2019年度中国非处方药企业及产品榜",
                "features": {
                    "keywords": [
                        "云南白药",
                        "非处方药",
                        "榜单"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-24",
                "original_text": "【民生医药】医药生物2019年三季报总结：基本面进入值得期待的新周期",
                "features": {
                    "keywords": [
                        "医药生物",
                        "三季报",
                        "基本面",
                        "新周期"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-10-24",
                "original_text": "【博星解盘】2019.10.24",
                "features": {
                    "keywords": [],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-10-24",
                "original_text": "各路资本争相布局工业大麻 “全产业链+海外布局”或成一大出路",
                "features": {
                    "keywords": [
                        "工业大麻",
                        "全产业链",
                        "海外布局"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "化工",
                        "农业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}